Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Changjun YuDivision of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E California Blvd, Pasadena, CA 91125, USA.ORCID 0000-0002-5722-6751
Faqing HuangDepartment of Chemistry and Biochemistry, The University of Southern Mississippi, Hattiesburg, MS 39406, USA.
Leslie WangSunstate Biosciences LLC, 118 S. Berkeley Ave, Pasadena, CA 91107, USA.
Mengmeng LiuSunstate Biosciences LLC, 118 S. Berkeley Ave, Pasadena, CA 91107, USA.
Warren A ChowDivision of Hematology and Oncology, Department of Medicine, UCI Health, Orange, CA 92868, USA.ORCID 0000-0003-0889-5841
Xiang LingDepartment of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Fengzhi LiDepartment of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA.ORCID 0000-0002-2299-7951
Galen Cook-WiensDepartment of Biomedical Sciences, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
Linrong LiDepartment of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100006, China.ORCID 0000-0003-4106-6463
Xiaojiang CuiDepartment of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.ORCID 0000-0002-6843-736X
Funding
The Role of FOXCI in Basal-like Breast CancerR01CA151610 · NCI · SAINT JOHN'S CANCER INSTITUTE · PI CUI, XIAOJIANG · 2011 to 2022
$3.8M
Crosslinking-based targeted therapy for triple-negative breast cancerR21CA280458 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI CHEN, SHENGXI, CUI, XIAOJIANG · 2023 to 2024
$418k
Department of Defense W81XWH-18-1-0067NCI NIH HHS R01 CA151610NCI NIH HHS R21 CA280458
6 · The paper itself
Abstract
As rare tumors, sarcomas represent ~0 [...].
Indexed as
cardiotoxicitydoxorubicinEwing sarcomaFcRn expression levelsingle protein encapsulationsoft tissue sarcomaSPEDOX-6toxicokinetictriple negative breast cancer
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Targeted Treatment of Sarcomas by Single Protein Encapsulated Doxorubicin with Undetectable Cardiotoxicity and Superior Efficacy. · full record | Socratic